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otirios Tsimikas, MD, FACC*
an Diego and Irvine, California
Diagnostic techniques to identify vulnerable plaques are rapidly evolving. Intravascular
ultrasound (IVUS) has the ability to detect and localize plaque as well as quantitate plaque
burden. Recent IVUS studies have suggested that patients presenting with acute coronary
syndromes have an approximate 25% incidence of additional ruptured plaques in arteries other
than the culprit lesion. The ability of IVUS to detect vulnerable plaques before rupture is
currently being evaluated by novel techniques. Initially, IVUS was shown to be able to
characterize plaque broadly as calcified or fibrofatty but was limited in its ability to more
precisely detect lipid-rich plaques, necrotic cores, and thrombus. Recent advances in new
applications of IVUS, such as integrated backscatter, wavelet analysis, and virtual histology,
have focused on evaluating and mathematically transforming the radiofrequency signal from
ultrasound waves into a color-coded representation of plaque characteristics such as lipid,
fibrous tissue, calcification, and necrotic core. In addition, targeted contrast agents, applicable
to both intravascular and transthoracic studies, are being evaluated in experimental models
and aim to highlight specific plaque components, such as endothelial adhesion molecules and
other plaque components that might be useful in targeting vulnerable plaques. These advances
pave the way for future clinical trials in assessing the ability of such techniques to diagnose
vulnerable plaques and to assess the effects of both pharmacologic and mechanical therapies
on plaque characteristics. (J Am Coll Cardiol 2006;47:C32–9) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.047College of Cardiology Foundation
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attempts to identify vulnerable plaques have focused on
maging techniques, including cardiac ultrasound. These
fforts have primarily employed intravascular ultrasound
IVUS), although recently contrast echocardiographic ap-
roaches have been pursued. Intravascular ultrasound was
ade possible by the miniaturization of ultrasound trans-
ucers so that they could be placed at the tip of very small
iameter catheters. With an IVUS catheter positioned in a
oronary artery, an ultrasound beam is directed perpendic-
lar to the course of the vessel and steered either electron-
cally or mechanically throughout its 360° circumference.
hereby, an image of cross-sectional arterial anatomy is
btained (1). Intravascular ultrasound’s cross-sectional im-
ges in normal arteries depict a sharp, bright endothelial/
umen border, a clear sonolucent media, and an echo dense
dventitia (2).
Plaque formation results in a thickening of the intimal-
edial segments and an overall thickening of the vessel wall.
laque morphology by ultrasound is often characterized by
he intensity of the signals as soft (gray) echoes, very high
ntensity (bright) reflectors that create distal shadowing, and
choes of intermediate intensity, features that correspond to
issue, calcification, and fibrosis (3). In addition, echolucent
r signal free zones have been found to represent lipid
ccumulations (4–7). Plaques might be circumferential and
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ccepted November 8, 2005.ccupy the entire perimeter of a vessel or be eccentric and
ccupy only a portion of the vessel wall. Atherosclerotic
esions often result in an expansion of the overall vessel to
ccommodate plaque without encroaching upon the lumen,
process termed positive remodeling (8). In addition,
uptures or ulcerations of lesions can be detected, typically in
ulprit vessels responsible for acute coronary syndromes
ACS) (9). Thus, an IVUS examination can detect and
ocalize plaque, characterize it as hypoechoic, fibrous, or
alcified, and determine whether it is ulcerated or manifests
ositive expansile remodeling. As compared with angiogra-
hy, which evaluates atherosclerosis only by its indirect
ffect upon the lumen, IVUS has the obvious advantage of
ooking directly at plaque contained within the vessel wall.
REVALENCE OF UNSTABLE PLAQUES
ngiographic and angioscopic studies. Data regarding
he prevalence of unstable plaques in patients undergoing
ardiac catheterization have been provided by angiography,
ngioscopy, and IVUS. These studies have corroborated
arlier pathologic studies (10). In a landmark angiographic
tudy, Goldstein et al. (11) showed that approximately 60%
f patients presenting with acute myocardial infarction
AMI) have single complex plaques, whereas approximately
0% of patients have multiple complex coronary plaques
hat portend a worse 1-year prognosis. The finding of
ultiple plaques with vulnerable characteristics is consistent
ith angioscopic data showing that approximately 90% of
ulprit, but not disrupted, lesions are yellow and are asso-
iated histologically with vulnerable characteristics (12). In
ddition, the prevalence of yellow plaques in non-culprit
esions per coronary artery was 3.2, suggesting a pan-
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April 18, 2006:C32–9 Imaging the Vulnerable Plaque by Ultrasoundoronary process. Interestingly, follow-up angioscopic stud-
es do suggest that complete plaque healing, manifested by
eointimal coverage of the disrupted plaque and resolution
f thrombus, occurs only in a minority of lesions at
3-month follow-up (13). It has recently been shown that
ipid-lowering therapy with atorvastatin reduced the yellow
core of such lesions, compared with a control group, which
ad increased yellow score (14).
VUS studies. Recently, several IVUS studies have ad-
anced these concepts by interrogating all three major
picardial vessels and quantitating the frequency of plaque
upture in patients presenting with ACS. In a small study
f 24 patients (72 arteries) with troponin-positive ACS,
ioufol et al. (15) showed a mean prevalence of two
uptured plaques (range 0 to 6) per patient; 37.5% of
atients had plaque rupture at the presumed culprit lesion,
nd 79% of patients also had ruptured plaques in non-
ulprit arteries. In addition, 12.5% of patients had plaque
upture in all three coronary arteries, and 69% of arteries
ad at least one plaque rupture. Hong et al. (16) showed in
35 patients that plaque rupture of the infarct-related vessel
ccurred in 66% of AMI patients and in 27% of stable
ngina patients. In addition, multiple plaque ruptures oc-
urred in 20% of AMI and 6% of stable angina patients.
anaka et al. (17) performed a similar study in patients with
CS and showed that 47% of culprit lesions had plaque
upture and that 24% of patients had plaque ruptures in
ore than one coronary artery. These data are consistent
ith other IVUS studies showing that culprit plaques have
ore vulnerable characteristics, such as more plaque burden,
ositive remodeling, and thrombus, than non-culprit
laques in patients with ACS (18,19). The overall preva-
ence of multiple ruptured coronary plaques in these studies
s a whole is approximately 25% (20); however, it is possible
hat this is an underestimate, because IVUS is limited in
dequately imaging plaque erosion and overlying thrombus,
hich might obscure ruptured plaques and the fact that
ome plaque ruptures might have occurred at bifurcations
nd branch vessels that were not imaged in these studies.
ifferences in the prevalence of plaque rupture in these
tudies also likely reflect differences in the patient popula-
ion, selection bias in IVUS imaging, and the retrospective
ature of some studies. Subsequently, Rioufol et al. (21) also
Abbreviations and Acronyms
3D-IB-IVUS  three-dimensional intravascular ultrasound
with integrated back scatter
ACS  acute coronary syndromes
ICAM  intracellular adhesion molecules
IVUS  intravascular ultrasound
PS  phosphatidylserine
RF  radiofrequencyhowed that approximately 50% of these plaques heal in Iesponse to medical therapy without significant change in
laque dimensions, as also previously documented in patho-
ogical studies showing multiple layers of plaque rupture and
ealing within the same area (22).
Recent studies have also shown that the pattern of
alcification is different in patients with ACS versus those
ith stable angina (23–25). Patients with ACS and ruptured
laques manifest a larger number of small, discrete calcium
eposits, often present as spotty superficial and/or deep
alcium deposits. Patients with ACS tended to have less
verall calcification than patients with stable angina pectoris
ut also more positive remodeling.
VUS PLAQUE CHARACTERIZATION
he initial attempts to identify vulnerable plaque by IVUS
nvolved defining the image characteristics of culprit lesions
hat had lead to ACS (9). A number of lesion characteristics
ere described in the majority of patients in this setting
Table 1). Although these characteristics were observed
ith variable frequency, it was generally found that these
laques were hypoechoic, eccentric, positively remodeled,
nd relatively free of calcification. Volumetric analysis of
VUS images accurately quantitate atheroma volume and
re useful in assessing changes in plaque regression and
rogression in trials of lipid lowering agents (26). Three-
imensional (3D) reconstruction allows morphological as-
essment of lesions but is not as useful in detecting clinically
elevant plaque characteristics such as lipid content.
Obviously, plaque vulnerability can only be assessed with
ertainty by serial observations that demonstrate the transi-
ion of a lesion from stability to instability. To date, only
ne study has made such serial observations. Yamagishi
t al. (27) examined 114 coronary sites in 106 patients by
VUS during a follow-up period of nearly 22 months. The
oronary sites at which an event occurred that had been
reviously examined were characterized by large, eccentric
esions. The vast majority of these plaques contained
cholucent zones that were usually shallow but occasionally
eep in the vessel wall. Subsequent studies have also verified
hat positive (outward) remodeling is typically found in
ulprit lesions. Thus, the IVUS characteristics of a vulner-
ble plaque that have emerged include eccentric lesions with
cholucent zones in areas of positive expansile remodeling.
Although, the IVUS descriptors of vulnerable plaque that
ave been proposed seem reasonable, a number of consid-
rations prevent them from being accepted as definitive.
able 1. IVUS Characteristics Associated With Culprit Lesions
) Echolucent core
) Eccentricity
) Positive remodeling
) Ulceration
) Thrombosis
) CalcificationVUS  intravascular ultrasound.
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Imaging the Vulnerable Plaque by Ultrasound April 18, 2006:C32–9early all of the studies upon which the descriptors are
ased have been retrospective. Knowing plaque morphology
fter an acute event cannot provide certain information
igure 1. (A) Three-dimensional (3D) color-coded maps of the coronary a
catter. (B) 3D color-coded maps of each characteristic. The number of v
ermission from Kawasaki et al. (29).
igure 2. Color-coded maps of the coronary arterial plaques constructed b
maging at baseline and after statin therapy. (A) At baseline. The plaque co
fter statin therapies. The lipid core (blue) decreased and the fibrous area
as a small lipid core (blue) in the center of the plaque. (D) Cut-out image of
ore. Red  high signal lesion; yellow  mixed lesion. Reprinted with permisegarding morphology before that episode. Secondly, the
haracteristics reported for vulnerable plaque by IVUS have
iffered from study to study. Thirdly, non-culprit plaques in
l plaques constructed by 3D intravascular ultrasound with integrated back
of each tissue characteristic was automatically calculated. Reprinted with
ee-dimensional (3D) intravascular ultrasound with integrated back scatter
s of a large lipid core (blue) that is covered with a fibrous cap (green). (B)
) increased. (C) Cut out image of 3D color-coded map at baseline. Thererteriay thr
nsist
(green3D color-coded map after statin therapy. Note the reduction in the lipid
sion from Kawasaki et al. (29).
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April 18, 2006:C32–9 Imaging the Vulnerable Plaque by Ultrasoundtable patients have often been found to show the same
haracteristics associated with vulnerable plaque. For exam-
le, a study by Schoenhagen et al. (28) found that culprit
esions from patients with ACS were identical in “vulnerable
VUS characteristics” to lesions observed in patients with
table angina, thereby casting uncertainty on the ability of
VUS to identify plaques susceptible to rupture, fissure, or
rosion. Fourthly, the resolution of IVUS (150 to 300 m)
s too low to detect thin fibrous caps (50 to 75 m), which
ave been identified as one of the features of vulnerable
laques.
These limitations notwithstanding, several novel ap-
roaches have recently been developed to more precisely
efine plaque characteristics.
D IVUS with integrated back scatter. Three-dimensional
VUS with integrated back scatter (3D-IB-IVUS) allows
olor coding and integration of sequential 1-mm segments
btained by motorized pullback to provide more optimal
laque characterization. Radiofrequency (RF) signals digi-
ized at 2 GHz can be obtained with a conventional 40
Hz IVUS catheter. Subsequent IB signals of the RF
ignal can be calculated and color coded, providing a
uantitative visual readout. This system uses a conventional
VUS instrument, a digital analog converter, and computer
oftware to identify, and quantitate, various plaque charac-
igure 3. Representative examples of in vitro Wavelet analysis of radiofre
A) and from a fibrous plaque without a lipid core (B). The upper panel sh
anel, histologic specimen of the corresponding arterial cross-section with
nalysis, an apparently different pattern of pink area from an RF signal vector of
ith the fibrous plaque. F  fibrous area; L  lipid core. Reprinted with permeristics. For example, Kawasaki et al. (29) recently de-
cribed the usefulness of 3D-IB-IVUS in detecting lipid-
ich plaques and monitoring their response to lipid lowering
herapy. They evaluated the tissue characteristics of a
oronary arterial segment 18-mm-long and then random-
zed patients to atorvastatin, pravastatin, or placebo for 6
onths. The 6-month 3-IB-IVUS images showed a signif-
cant reduction in lipid volume and a similar increase in
brous and mixed lesion volume in response to both statins
ut not to placebo (Figs. 1 and 2). These changes were
etected despite no significant changes in lumen area, vessel
rea, plaque area, and diameter stenosis, further defining the
bility of this technique to identify early changes in plaque
haracteristics before geometric plaque regression and sug-
esting a role for defining plaque stabilization.
avelet analysis. Wavelet analysis of RF IVUS signals is
novel mathematical model for assessing focal differences
ithin arterial walls. Color coding of the wavelet correlation
oefficient derived from the RF signal allows detection of
hanges in the geometrical profile of time-series signals to
erive an image of plaque components (Figs. 3 and 4). With
avelet analysis, Murashige et al. (30) showed that lipid-
ich plaques, derived from necropsy specimens and subse-
uently confirmed as such by histology, could be detected
ith a sensitivity of 83% and specificity of 83% in an in vitro
y (RF) intravascular ultrasound (IVUS) signals from a lipid-laden plaque
F signals, the middle panel, the results of Wavelet analysis, and the lower
on’s trichrome. In the time-scale domain color-coded mapping of Waveletquenc
ows R
Massa lipid-laden plaque is observed between scale 20 and scale 30, compared
ission from Murashige et al. (30).
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Imaging the Vulnerable Plaque by Ultrasound April 18, 2006:C32–9ystem. Furthermore, IVUS imaging of the coronary arteries
erformed in 13 patients showed similar results with con-
rmation of the presence of lipid-rich components by
istology after obtaining tissue by directional atherectomy.
irtual histology. “Virtual histology” applies spectral anal-
sis of the IVUS backscatter RF signal to characterize
laque components on the basis of tissue characteristics such
s density, compressibility, concentration of various compo-
ents, and size. With quantitative spectral parameters and
dvanced mathematical techniques to classify plaque com-
osition, this approach has been validated with histological
echniques on ex vivo coronary specimens in classifying
esions as calcified, fibrofatty, calcified-necrotic core, and
ipid-rich areas (31,32). This methodology allows real-time,
D plaque cross-sectional and longitudinal views of the
ntire vessel and allows one to visualize the complete length
f the artery and assess individual plaque components.
lthough this technique seems promising and is currently at
he forefront of this approach, its clinical usefulness awaits
ngoing clinical trials.
These refinements of IVUS suggest that identification of
laque characteristics, including lipid-rich components,
ight be clinically feasible in the near future and might
llow identification of vulnerable plaques and new avenues
igure 4. Representative examples of in vivo Wavelet analysis of radiofrequ
nd from a fibrous plaque without a lipid core (B). The left panel shows
he right panel, histologic cross section of the corresponding directional
imilar pattern of color mapping was observed from the RF signal vector o
rom Murashige et al. (30).f diagnosis and therapy. nVUS AND TRANSTHORACIC
LTRASOUND WITH TARGETED CONTRAST AGENTS
ecent years have seen the development of new micro-
ubble ultrasound contrast agents and enhanced recording
nstrumentation that enable the opacification and visualiza-
ion not only of the cardiac chambers but also blood vessels
nd myocardium (33). Thus, myocardial contrast echocar-
iography can provide visualization of myocardial perfusion
fter the intravenous injection of a variety of ultrasonic
ontrast agents; however, the microbubble agents have a
nite lifespan before dissolving and might be destroyed by
he ultrasound energy applied in the process of imaging. In
ddition, the generalized myocardial and vascular opacifica-
ion produced by contrast echocardiography might mask
ptake of microbubbles by plaque. Therefore, there are a
umber of challenges to identifying vulnerable plaque by
ontrast echocardiography.
Imaging methods to detect vulnerable plaque have often
een based on targeted imaging with the use of a signal-
enerating compound that, when attached to the target of
nterest, is detectable by the imaging technique. For ultra-
ound, the “beacon” that can be detected is the signal from
icrobubble contrast agents. Assuming that the target is
pecific for plaque (vulnerable or otherwise), it is not
RF) intravascular ultrasound (IVUS) signals from a lipid-laden plaque (A)
ntional IVUS images, the middle panel, the results of Wavelet analysis,
ary atherectomy specimen with Hematoxylin-Eosin and Azan stains. A
pid-laden plaque as seen in the in vitro study. Reprinted with permissionency (
conve
coronecessary to image the vessel to establish the presence of the
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April 18, 2006:C32–9 Imaging the Vulnerable Plaque by Ultrasoundarget. Thus far, contrast echo has been confined primarily
o the identification of white blood cells and endothelial cell
urface markers such as adhesion molecules; however, the
rinciples will be the same for identifying specific markers of
ulnerable plaque when they are defined.
In light of the aforementioned issues, the strategy that
as emerged to achieve targeted diagnostic imaging by con-
rast echocardiography has been to have the microbubbles or
coustically reflective liposomes ingested by or attached to the
pecific target to be visualized (33,34). Attachment has been
chieved either by virtue of the inherent properties of the
icrobubble shell or by attaching specific ligands such as
onoclonal antibodies. In experimental models, these micro-
ubbles are then injected, and after a suitable time is allowed
or either ingestion or attachment, conventional echocar-
iographic recordings are obtained. In this fashion the bulk
f the contrast injected has disappeared, and the only
esidua are the microbubbles ingested by or attached to the
arget.
igure 5. The top panel shows the dissected intact aorta (left) and the o
aseline ultrasound image of the aortic plaque (arrow), (B) shows micro
icrobubble enhancement of the aortic plaque about 25 min after injecti
ltrasound imaging was done after 25 min. Note the brighter appearance
he left is the baseline image of a plaque and the figure on the right is color-code
theroma.Although most microbubble ultrasonic contrast agents
apidly transit the capillary bed, it was an early observation
hat some microbubble agents became transiently attached
o vessels, particularly venules (35). Subsequent studies
elated this prolonged residence within the microcirculation
o a negative surface charge of the bubble (usually due to a
ipid shell) with subsequent phagocytosis by white blood
ells gathered along the surface of the endothelium. To date
he ingestion of microbubbles by leukocytes has been found to
e sufficiently avid to enable identification of inflammation
uch as that encountered after ischemia/reperfusion or trans-
lant rejection in the experimental setting (36,37).
The detection of white blood cells associated with plaque
nflammation as a marker of vulnerable plaque would present a
erious challenge; however, an alternate approach consists of
sing microbubble contrast to identify leukocyte adhesion
olecules such as selectins or integrins, which might be
pregulated in vulnerable plaque. Initial in vitro studies,
mploying either microbubble contrast agents or lipid emul-
d aorta (right) showing yellow plaques. In the middle panel, (A) shows
les in the aortic lumen soon after intravenous injection, and (C) shows
he lumen is free of circulating microbubbles, and high mechanical index
plaque. The lower panel shows another example in which the figure onpene
bubb
on. T
of thed, baseline-subtracted, videointensity image of the microbubble-enhanced
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Imaging the Vulnerable Plaque by Ultrasound April 18, 2006:C32–9ions to which antibodies to intracellular adhesion mole-
ules (ICAM) had been incorporated, documented the
bility of these agents to attach to and be visualized on
ndothelium in which these molecules had been upregulated
38). Subsequently, targeted identification of leukocytes ad-
erent to the endothelium of venules was accomplished by
icrobubbles to which phosphatidylcholine was incorpo-
ated into the lipid shell. Microbubbles, to which ligands to
CAM1 have been incorporated, have also been used to
isualize transplant rejection in the experimental setting
39). Thus, exploiting both shell characteristics and incor-
orated ligands to specific targets, microbubbles have been
ound to be capable of identifying white blood cells as well
s adhesion molecules (34,40). Imaging of additional in-
ammatory targets, such as phosphatidylserine (PS) recep-
ors, which are ubiquitously expressed by macrophages, are
eing explored with echogenic liposomes enriched in PS
hospholipids (Fig. 5). The imaging was performed with
he premise that these bubbles will be preferentially at-
racted by the lesions that harbor abundant macrophages (or
ulnerable plaque). With this hypothesis, experimental
therosclerotic lesions were developed in rabbits by bal-
oon de-endothelialization of the infradiaphragmatic
orta, followed by 1% cholesterol, 6% peanut oil diet for
months. Such animals develop American Heart Asso-
iation type II (20%), III (30%), and IV (50%) lesions.
ntravenous administration of PS-rich microbubbles filled
ith perfluorocarbon were injected, and images were re-
orded showing enhancement of the aortic plaque. The
otential for additional endothelial cell surface markers to
e used as targets for contrast echo detection of atheroscle-
osis is obvious.
A number of challenges exist to the detection of vulnerable
laque by targeted echocardiographic contrast imaging. To
egin with, it must be possible to achieve a minimum concen-
ration of microbubbles at the target site. Secondly, the number
f microbubbles and the ultrasonic signal transmitted must be
apable of generating a sufficiently strong signal from the
ethered/ingested microbubbles. Finally, one must be able to
istinguish the resident microbubbles from both circulating
icrobubbles and from ultrasonic signals generated by the
lood-intimal border. Thus, targets must be chosen that are
resent in sufficient quantity and that can attract an ade-
uate number of microbubbles per target to be detected by
xternal ultrasonic imaging. Given these constraints, it is
ikely that targeted imaging by contrast echocardiography
ight find that detecting vulnerable plaque in the carotid
rteries or in the coronary arteries in conjunction with IVUS
maging will be its initial clinical application. Contrast
chocardiography offers the opportunity to detect vulnerable
laque by noninvasive imaging but presents significant
hallenges to the recording of microbubbles tethered to
pecific sites. Nevertheless, the safety, repeatability of re-
ording, portability, and cost of ultrasound provide a sub-
tantial incentive to develop approaches using this modality
or the identification of vulnerable plaque.
1ONCLUSIONS
t the moment, intravascular and transthoracic ultrasonic
echniques for the detection of vulnerable plaque must be
onsidered as either not established or experimental. Recent
dvances, however, suggest that plaque characterization
ith a variety of techniques might be feasible. Ultimately,
linical trials will determine whether ultrasound approaches
ight identify vulnerable plaques or result in new algo-
ithms in patient care.
eprint requests and correspondence: Dr. Anthony N.
eMaria, Cardiology Division, UCSD Medical Center, 200
est Arbor Drive, San Diego, California 92103-8411. E-mail:
demaria@ucsd.edu.
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